Production (Stage)
Calithera Biosciences, Inc.
CALA
$0.0001
$0.000.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -39.65M | -101.92M | -103.29M | -108.53M | -115.09M |
| Total Depreciation and Amortization | 255.00K | 255.00K | 262.00K | 271.00K | 280.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.21M | 45.64M | 46.80M | 50.68M | 51.91M |
| Change in Net Operating Assets | -7.43M | -4.56M | -4.22M | -2.73M | -3.41M |
| Cash from Operations | -43.61M | -60.58M | -60.45M | -60.31M | -66.30M |
| Capital Expenditure | -133.00K | -149.00K | -257.00K | -147.00K | -147.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 1.50M | 8.00M |
| Cash from Investing | -133.00K | -149.00K | -257.00K | 1.35M | 7.85M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.66M | 10.48M | 10.47M | 2.44M | 10.84M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -173.00K | -173.00K | -173.00K | -173.00K |
| Cash from Financing | 9.66M | 10.31M | 10.29M | 2.27M | 10.67M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.09M | -50.43M | -50.42M | -56.69M | -47.78M |